Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Communications & Outreach

Communications & Outreach

                        FDA Commission Validation
          Non-Binding Agreements with the FDA Office of Regulatory Affairs
          ORA’s Return-on-Investment Assessment  for State Partnership Agreements
          Commissioning
          Information Sharing
          Methods Of Communication
          Regulatory Associations
          State and Local Inquiries


                        News & Events Home
          For Federal, State, Local, Tribal, and Territorial Officials
          Communications & Outreach
          ORA’s Return-on-Investment Assessment  for State Partnership AgreementsCommunications & Outreach ORA’s Return-on-Investment Assessment  for State Partnership Agreements
  
  	
    Share
    Post
    Linkedin

    Email
    PrintThe U.S. Food and Drug Administration and our regulatory partners have a shared mission: Ensuring the food we eat is safe. This mission can only be achieved by fully leveraging the resources, expertise, and capabilities as part of an integrated food safety system.

In close collaboration with our regulatory partners, the FDA/Office of Regulatory Affairs (ORA) has implemented multiple programs to strengthen our partnerships and advance food safety over the past several years. ORA is conducting a comprehensive return-on-investment (ROI) assessment across these domestic human and animal food partnership programs as part of our commitment to continuous improvement. The scope of our analysis will cover funded programs, such as the state inspection contracts and capacity building efforts supported through grants and cooperative agreements. The analysis will also include other ORA programs and services that support partnerships, such as training, partnership agreements, and data exchange.

Our goal is to understand the collective long-term costs and benefits of each partnership program across our State, Local, Tribal and Territorial (SLTT) partners and regulatory associations. For example, understanding the sustainability of a partnership program, both for the FDA and our regulatory partners, promotes better long-term resource planning and helps to prevents budgetary challenges and operational disruption for both the FDA and our SLTT partners. The assessment will also help measure the relevance that these partnership programs have in promoting not just the FDA’s mission and priorities, but the missions and priorities of our regulatory partners. As we continue advancing a stronger, more collaborative relationship with state and local agencies, the crucial perspectives and insights of our regulatory partners will be actively solicited over the coming months and fully incorporated into the assessment.

The assessment’s findings will capture the historical and comparative analysis of various partnership programs and include initial recommendations intended to support, advance, and inform future state partner initiatives. In addition, the assessment serves to provide a foundational evaluative framework of ORA and partner programs and, as such, poses no immediate impact or disruptive changes to ongoing operations. Once this assessment is complete, ORA looks forward to sharing the findings and seeking feedback from our partners on the proposed recommendations and how best to further a cooperative environment where our shared mission is mutually advanced through these partnership programs. The continued close collaboration with our regulatory partners is essential to ensuring potential initiatives and changes are mutually beneficial and provide long-term, sustainable solutions.

Please feel free to provide any questions, comments, or concerns related to this project to our centralized mailbox.

                                                                                  Content current as of:
      11/09/2023Communications & Outreach

          
                        FDA Commission Validation
          Non-Binding Agreements with the FDA Office of Regulatory Affairs
          ORA’s Return-on-Investment Assessment  for State Partnership Agreements
          Commissioning
          Information Sharing
          Methods Of Communication
          Regulatory Associations
          State and Local Inquiries


                        News & Events
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop